Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul E Beaumont

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Ophthalmology|August 5, 2009
Ranibizumab and nonocular hemorrhagePaul E Beaumont, H Kwon Kang
Clinical & Experimental Ophthalmology|January 27, 2005
Balancing the risks and benefits in AMDPaul E Beaumont, Hyong K Kang
Ophthalmology|August 17, 2010
Erratum: Ranibizumab and Nonocular HemorrhagePaul E Beaumont, H Kwon Kang
Archives of Ophthalmology (Chicago, Ill. : 1960)|June 14, 2006
Lesion morphology in age-related macular degeneration and its therapeutic significancePaul E Beaumont, H Kwon Kang
Ophthalmology|February 5, 2002
Cup-to-disc ratio, intraocular pressure, and primary open-angle glaucoma in retinal venous occlusionPaul E Beaumont, H Kwon Kang
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|December 16, 2014
The effect of intensive education on concordance with the Age-Related Eye Disease Study (AREDS) recommendations in a tertiary referral practiceTravers R E Weaver, Paul E Beaumont
Ophthalmology|November 26, 2013
Is there risk of stroke with aflibercept?Paul E Beaumont, Peter Petocz, Hyong K Kang
Retina (Philadelphia, Pa.)|April 23, 2003
Case series outcomes at 1 week following verteporfin photodynamic therapyWeichuan Tan, Paul E Beaumont, Andrew A Chang
Clinical & Experimental Ophthalmology|March 22, 2003
Limited macular translocation for subfoveal choroidal neovascularization in age-related macular degenerationAndrew A Chang, Weichuan Tan, Paul E Beaumont, et al.
Clinical & Experimental Ophthalmology|July 22, 2005
Visual outcomes following vitrectomy and peeling of epiretinal membraneJames G Wong, Nitin Sachdev, Paul E Beaumont, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Ophthalmology|August 5, 2009
Ranibizumab and nonocular hemorrhagePaul E Beaumont, H Kwon Kang
Clinical & Experimental Ophthalmology|January 27, 2005
Balancing the risks and benefits in AMDPaul E Beaumont, Hyong K Kang
Ophthalmology|August 17, 2010
Erratum: Ranibizumab and Nonocular HemorrhagePaul E Beaumont, H Kwon Kang
Archives of Ophthalmology (Chicago, Ill. : 1960)|June 14, 2006
Lesion morphology in age-related macular degeneration and its therapeutic significancePaul E Beaumont, H Kwon Kang
Ophthalmology|February 5, 2002
Cup-to-disc ratio, intraocular pressure, and primary open-angle glaucoma in retinal venous occlusionPaul E Beaumont, H Kwon Kang
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|December 16, 2014
The effect of intensive education on concordance with the Age-Related Eye Disease Study (AREDS) recommendations in a tertiary referral practiceTravers R E Weaver, Paul E Beaumont
Ophthalmology|November 26, 2013
Is there risk of stroke with aflibercept?Paul E Beaumont, Peter Petocz, Hyong K Kang
Retina (Philadelphia, Pa.)|April 23, 2003
Case series outcomes at 1 week following verteporfin photodynamic therapyWeichuan Tan, Paul E Beaumont, Andrew A Chang
Clinical & Experimental Ophthalmology|March 22, 2003
Limited macular translocation for subfoveal choroidal neovascularization in age-related macular degenerationAndrew A Chang, Weichuan Tan, Paul E Beaumont, et al.
Clinical & Experimental Ophthalmology|July 22, 2005
Visual outcomes following vitrectomy and peeling of epiretinal membraneJames G Wong, Nitin Sachdev, Paul E Beaumont, et al.
Pageof 2